Patents
Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027)
04/2005
04/12/2005US6878698 Anti-inflammatory androstane derivatives
04/07/2005WO2005030120A2 Antiangiogenic agents
04/07/2005CA2527074A1 Antiangiogenic agents
04/05/2005CA2170286C Synthesis of 17-(3-pyridyl) steroids
03/2005
03/31/2005US20050070515 Glucocorticosteroids which are hydrolysable in human or animal blood by lactonase enzyme; for treatment of respiratory and gastrointestinal disorders; side effect reduction
03/31/2005US20050069267 Method of making spun optical fiber with low PMD
03/29/2005CA2100514C 17-spiromethylene steroids
03/16/2005EP1513509A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
03/16/2005EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides
03/10/2005US20050054622 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound
02/2005
02/24/2005US20050043285 Formulation
02/24/2005US20050043284 containing an anti-inflammatory and anti-allergic compound of the androstane series
02/23/2005CN1585777A 肝脏x受体激动剂 Liver x receptor agonist
02/22/2005US6858593 Composition in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in the crystalline composition is of space group P212121 having unit cell dimensions of about 7. 6+-0.6 Angstrom , 12.7+-0.7 Angstrom ,
02/15/2005CA2124339C Novel 19-nor steroids having a thiocarbon-containing chain in the 11 beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositionscontaining said steroids
02/03/2005WO2005009361A2 Method of treating hit patients with argatroban
02/03/2005US20050026888 Formulation containing anti-inflammatory androstane derivatives
02/02/2005CN1187367C 3 alpha-hydroxy-3 beta-methoxymethyl-21-heterocycle substd. steroids with anesthetic activity
01/2005
01/20/2005US20050014737 Antiangiogenic agents
01/19/2005EP1497310A2 A process for the preparation of 6 alfa-fluoro steroids by isomerisation of 6.beta.-fluorosteroids
01/12/2005EP1494533A2 Farnesoid x-activated receptor agonists
12/2004
12/30/2004US20040266744 useful as intermediates in the preparation of steroids having medicinal properties
12/28/2004US6835724 Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds
12/16/2004WO2004074309A8 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates
12/15/2004EP0837874B1 Neuroactive steroids of the androstane and pregnane series
12/09/2004US20040248867 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
12/02/2004US20040241801 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
12/02/2004CA2489124A1 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
12/01/2004EP1480996A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
11/2004
11/17/2004EP1392713A4 Liver x receptor agonists
11/11/2004US20040225139 a 3-oxo-androstrane carbothioic acid compound
11/11/2004US20040224934 3 -oxo-androstrane carbothioic acid compound
11/11/2004US20040224932 crystal structure; antiinflammatory agents; antiallergens
11/11/2004US20040224931 3-oxo-androstrane carbothioic acid compound
11/10/2004EP1474436A2 Process for the production of fluticasone propionate, in particular of polymorphic form 1
11/04/2004US20040220162 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/04/2004US20040220157 a 3-oxoandrostrane carbothioic acid compound
11/04/2004US20040220156 Novel anti-inflammatory androstane derivative compositions
11/03/2004EP1472272A1 Crystalline complexes of fluticasone 2-furoate
11/03/2004EP1472271A1 Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy)-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid
11/03/2004EP1471919A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
11/03/2004EP1471900A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions
10/2004
10/28/2004WO2004092193A1 Process for preparing ursodeoxycholic acid di-sodium 3,7-disulfate
10/28/2004CA2522720A1 Process for preparing ursodeoxycholic acid di-sodium 3,7-disulfate
10/21/2004US20040209854 Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
10/14/2004WO2004087731A1 Process for the preparation of steroidal carbothioic acid derivatives and intermediates
10/14/2004CA2530680A1 Process for the preparation of steroidal carbothioic acid derivatives and intermediates
10/13/2004EP1466920A1 Process for the preparation of steroidal 17 beta-carbothioates
10/07/2004US20040198670 Novel estrogenic compounds
10/06/2004EP1464650A2 Novel estrogenic compounds, obtainable by heat treatment of conjugated estrogens in high humidity
10/06/2004EP1463748A2 Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
09/2004
09/30/2004US20040191874 Process for preparation of 9, 11-epoxy steroids and intermediates useful therein
09/30/2004DE4120124B4 Verfahren zur Herstellung von Derivaten des Cholesterols und seiner Homologen Process for the preparation of derivatives of cholesterol and its homologues
09/16/2004WO2003066063A8 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
09/15/2004EP1257531B1 Method for the preparation of carbothioic acids
09/14/2004CA2254079C Androstene derivatives
09/09/2004DE10307105A1 Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate Antitumor effective 2-substituted 18a-Homoestra-1,3,5 (10) -triene-3-yl sulfamates
09/09/2004DE10307103A1 Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate Antitumor effective 2-substituted D-Homostra-1,3,5 (10) -triene-3-yl sulfamates
09/08/2004CN1527838A Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha
09/02/2004WO2004074309A1 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates
09/02/2004WO2004074308A1 Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates
09/02/2004US20040171597 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
09/02/2004CA2516185A1 Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates
09/02/2004CA2516184A1 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates
08/2004
08/26/2004DE19642875B4 Verfahren zur Herstellung von Sterolsulfaten Process for the preparation of sterol sulfates
08/24/2004US6780855 Treating a patient suffering from an estrogen dependent-disease
08/24/2004US6780853 For modulating brain excitability
08/19/2004US20040162425 6,7-Oxygenated steroids and uses related thereto
08/17/2004US6777400 Anti-inflammatory androstane derivative compositions
08/17/2004US6777399 Anti-inflammatory androstane derivative compositions
08/12/2004US20040157814 6, 7-Oxygenated steroids and uses related thereto
08/11/2004EP1444248A2 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha
08/10/2004US6774122 Sustained release; injection of fulvestrant
07/2004
07/29/2004DE10303671A1 New 8alpha,14beta-dialkyl-18-nor steroids useful as pharmaceuticals, intermediates or carriers for treating e.g. tumors, alzheimers disease
07/29/2004DE10303670A1 New 14beta-alkyl-18-nor steroids useful as pharmaceuticals, e.g. for treating inflammation or tumors, or pharmaceutical intermediates
07/29/2004DE10303667A1 New 14-fluoro-15,17-dihydroxysteroid derivatives, useful for treating Alzheimer's disease and tumors, and as intermediates, are e.g. inhibitors of steroid dehydrogenase
07/15/2004WO2004058795A1 Angiogenic compounds and uses thereof
07/15/2004WO2004011663A3 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
07/15/2004US20040138486 Steroid with cyclohexene and oxidized unsaturated ketone oxidized with copper iodide and tert-butyl hydroperoxide
07/15/2004CA2508913A1 Angiogenic compounds and uses thereof
07/08/2004WO2004012653A3 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
07/06/2004US6759398 Anti-inflammatory androstane derivative
06/2004
06/24/2004WO2004052912A1 17.beta- (alpha-hydroxy) -esters of androstanes as intermediates for the preparation for the preparation of 17.beta.-fluorinated-androstane esters
06/24/2004CA2510609A1 17.beta- (alpha-hydroxy) -esters of androstanes as intermediates for the preparation for the preparation of 17.beta.-fluorinated-androstane esters
06/23/2004EP1431305A1 Thiocarboxylic acid organic salts and processes utilizing the same
06/17/2004US20040116724 Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
06/17/2004US20040116396 Thiocarboxylic acid organic salts and processes utilizing the same
05/2004
05/27/2004WO2002090375A8 Liver x receptor agonists
05/19/2004EP1418921A1 Anti-tumour 2-alkoxyestradiol sulfamates
05/19/2004CN1498222A Steroidal derivatives
05/06/2004WO2004011663A9 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
05/06/2004EP0775155B1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them
04/2004
04/29/2004WO2003086303A3 Farnesoid x-activated receptor agonists
04/08/2004WO2004001369A3 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate
04/08/2004WO2003105775A3 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
04/08/2004US20040067917 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
04/07/2004EP1404700A2 Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation and intermediates of this process
04/07/2004CN1144813C Noval pregnane derivatives without substituting group at 17šŒlpha position, itsapplication as medicine preparing method and intermediate thereof and related compounds
04/07/2004CN1144812C Androstene derivative
03/2004
03/25/2004WO2004024745A2 Complexes of 6.alpha. 9.alpha. - difluoro - 17. alpha. - [ (2 - furanylcarbonyl) oxy] - 11.beta. -hydroxy - 16- .alpha. -methyl - 3oxo- androsta- 1,4 -diene - 17 .beta. -carbothioic acid s-fluoromethyl ester
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 21